RAFAEL HOLDINGS, INC. Accrued Liabilities, Current
RAFAEL HOLDINGS, INC. (RFL) had Accrued Liabilities, Current of $2.76 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-06-11
- 2026-04-30: Accrued Liabilities, Current $2.76M.
- 2026-01-31: Accrued Liabilities, Current $2.78M.
- 2025-10-31: Accrued Liabilities, Current $3.86M.
- 2025-07-31: Accrued Liabilities, Current $3.30M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-04-30 | $2.76M 10-Q · filed 2026-06-11 |
| 2026-01-31 | $2.78M 10-Q · filed 2026-03-16 |
| 2025-10-31 | $3.86M 10-Q · filed 2025-12-12 |
| 2025-07-31 | $3.30M 10-Q · filed 2026-06-11 |
| 2025-04-30 | $1.87M 10-Q · filed 2025-06-11 |
| 2025-01-31 | $1.41M 10-Q · filed 2025-03-14 |
| 2024-10-31 | $1.38M 10-Q · filed 2024-12-11 |
| 2024-07-31 | $1.80M 10-K · filed 2025-10-29 |
| 2024-04-30 | $1.75M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $845.00K 10-Q · filed 2024-03-14 |
| 2023-10-31 | $325.00K 10-Q · filed 2023-12-14 |
| 2023-07-31 | $763.00K 10-K/A · filed 2024-12-20 |
| 2023-04-30 | $592.00K 10-Q · filed 2023-06-13 |
| 2023-01-31 | $1.33M 10-Q · filed 2023-03-14 |
| 2022-10-31 | $1.60M 10-Q · filed 2022-12-13 |
| 2022-07-31 | $1.88M 10-K · filed 2023-10-30 |
| 2022-04-30 | $1.33M 10-Q · filed 2022-06-14 |
| 2022-01-31 | $6.62M 10-Q · filed 2022-03-17 |
| 2021-10-31 | $1.29M 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $1.23M 10-K · filed 2022-10-31 |
| 2021-04-30 | $861.00K 10-Q · filed 2021-06-14 |
| 2021-01-31 | $643.00K 10-Q · filed 2021-03-17 |
| 2020-10-31 | $443.00K 10-Q · filed 2020-12-15 |
| 2020-07-31 | $1.19M 10-K · filed 2021-10-18 |
| 2020-04-30 | $728.00K 10-Q · filed 2020-06-09 |
| 2020-01-31 | $579.00K 10-Q · filed 2020-03-05 |
| 2019-10-31 | $564.00K 10-Q · filed 2019-12-09 |
| 2019-07-31 | $605.00K 10-K · filed 2020-10-29 |
| 2019-04-30 | $203.00K 10-Q · filed 2019-06-05 |
| 2019-01-31 | $650.00K 10-Q · filed 2019-03-12 |
| 2018-10-31 | $431.00K 10-Q · filed 2018-12-10 |
| 2018-07-31 | $500.00K 10-K · filed 2019-10-04 |
| 2018-04-30 | $296.00K 10-Q · filed 2018-06-11 |
| 2018-01-31 | $423.00K 10-Q · filed 2018-03-12 |
| 2017-07-31 | $213.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |